{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:45:13Z","timestamp":1794293113908,"version":"4.9.0"},"reference-count":76,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gal?pagos NV"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2024,6,13]]},"DOI":"10.1021\/acs.jmedchem.4c00769","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:02:31Z","timestamp":1716919351000},"page":"8545-8568","source":"Crossref","is-referenced-by-count":17,"title":["Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases"],"prefix":"10.1021","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-9254","authenticated-orcid":true,"given":"Oscar","family":"Mammoliti","sequence":"first","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2788-3857","authenticated-orcid":true,"given":"S\u00e9bastien","family":"Martina","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-7749","authenticated-orcid":true,"given":"Pieter","family":"Claes","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5694-704X","authenticated-orcid":true,"given":"Ghjuvanni","family":"Coti","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Blanque","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Jagerschmidt","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shoji","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Borgonovi","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-9081","authenticated-orcid":true,"given":"Steve","family":"De Vos","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Marsais","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Oste","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Quinton","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"L\u00f3pez-Ramos","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Amantini","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Brys","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Miguel","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Galien","sequence":"additional","affiliation":[{"name":"Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"van der Plas","sequence":"additional","affiliation":[{"name":"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"9","key":"ref1\/cit1","first-page":"1329","volume":"5","author":"Firmbach-Kraft I.","year":"1990","journal-title":"Oncogene"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1021\/jm401490p"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3519"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051001"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010048"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.537"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1964-1"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01800"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219012"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.51"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.011"},{"key":"ref12\/cit12","unstructured":"U.S. Food and\nDrug Administration,\nGuselkumab Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761061s007lbl.pdf (accessed Aug 11, 2022)."},{"key":"ref13\/cit13","unstructured":"U.S. Food and Drug Administration,\nRisankizumab Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761262s000lbl.pdf (accessed Aug 11, 2022)."},{"key":"ref14\/cit14","unstructured":"U.S. Food and Drug Administration,\nTildrakizumab Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/761067s000lbl.pdf (accessed Aug 11, 2022)."},{"key":"ref15\/cit15","unstructured":"U.S. Food and Drug Administration,\nUstekinumab Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761044s010lbl.pdf (accessed Aug 11, 2022)."},{"key":"ref16\/cit16","unstructured":"European Medicines Agency,\nIlumetri EPAR: Product Information. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ilumetri (accessed\nAug 11, 2022)."},{"key":"ref17\/cit17","unstructured":"European Medicines Agency,\nSkyrizi EPAR: Product Information. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/skyrizi-epar-product-information_en.pdf (accessed Aug 11, 2022)."},{"key":"ref18\/cit18","unstructured":"European Medicines Agency,\nStelara EPAR: Product Information. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/stelara-epar-product-information_en.pdf (accessed Aug 11, 2022)."},{"key":"ref19\/cit19","unstructured":"European Medicines Agency,\nTremfya EPAR: Product Information. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tremfya-epar-product-information_en.pdf (accessed Aug 11, 2022)."},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1492545"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-06932-4"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0096"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1812201"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1002\/art.42391"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15006"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21805"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.2119\/2006-00085.Baechler"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.887"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2020-0425"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205440"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00444"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00649-y"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221664"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.5020a"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00948"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.03.059"},{"key":"ref37\/cit37","unstructured":"Nimbus Therapeutics Presents Additional\nClinical Data from Phase\n1 Studies of Oral Allosteric TYK2 Inhibitor at SID Annual Meeting, May 19, 2022. https:\/\/www.nimbustx.com\/2022\/05\/19\/nimbus-therapeutics-presents-additional-clinical-data-from-phase-1-studies-of-oral-allosteric-tyk2-inhibitor-at-sid-annual-meeting\/"},{"key":"ref38\/cit38","unstructured":"Armstrong, A. W. Efficacy and safety results from the randomized, double-blind, placebo-controlled phase 2b trial of TYK2 inhibitor NDI-034858 in moderate-to-severe psoriasis. American Academy of Dermatology Annual Meeting  2023, Oral abstract #S025."},{"key":"ref39\/cit39","unstructured":"Ventyx Biosciences to report topline results from the phase 1 trial\nof its TYK2 inhibitor VTX958 and second quarter 2022 financial results\non August 15, 2022, Ventyx Biosciences, Aug 11, 2022. https:\/\/ir.ventyxbio.com\/news-releases\/news-release-details\/ventyx-biosciences-report-topline-results-phase-1-trial-its-tyk"},{"key":"ref40\/cit40","unstructured":"Mammoliti, O.; Menet, C.; Cottereaux, C.; Blanc, J.; De Blieck, A.; Coti, G.; Geney, R.; Oste, L.; Ostyn, K.; Palisse, A.;  Design of a potent and selective dual JAK1\/TYK2 inhibitor [Unpublished results]."},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00077"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2013.01.005"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1021\/cb5002125"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.239723"},{"issue":"12","key":"ref45\/cit45","first-page":"1359","volume":"25","author":"Obach R. S.","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01263"},{"key":"ref47\/cit47","unstructured":"ADMET Predictor, SimulationsPlus. https:\/\/www.simulations-plus.com\/software\/admetpredictor\/ (accessed Aug 11, 2022)."},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1021\/jm901241e"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1021\/jm4008642"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00686"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00027"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00600"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201348"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060244"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5438"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1021\/jm400266t"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806382"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1002\/hlca.19600430116"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.402"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-010-9349-1"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-007-9133-z"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2010.05.020"},{"key":"ref63\/cit63","unstructured":"Structural and Thermodynamic Characterization\nof the TYK2 and JAK3\nKinase Domains in Complex with CP-690550 and CMP-6. Worldwide Protein Data Bank WWPDB. https:\/\/www.wwpdb.org\/pdb?id=pdb_00003lxn (accessed May 11, 2023)."},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.01.041"},{"key":"ref65\/cit65","unstructured":"Crystal structures of JAK1 and JAK2 inhibitor\ncomplexes. Worldwide Protein Data Bank WWPDB. https:\/\/www.wwpdb.org\/pdb?id=3EYG (accessed May 11, 2023)."},{"key":"ref66\/cit66","unstructured":"RCSB Protein Data Bank\n(PDB). https:\/\/www.rcsb.org\/ (accessed\nAug 11, 2022)."},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-013-9644-8"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","unstructured":"Bowers, K. J.; Chow, D. E.; Xu, H.; Dror, R. O.; Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D.;  Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters.  ACM\/IEEE Conference on Supercomputing, 2006; p 4310.1109\/SC.2006.54.","DOI":"10.1109\/SC.2006.54"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1021\/jm0306430"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1021\/jm051256o"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1021\/jm030644s"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1002\/qua.24481"},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1063\/1.3382344"},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevB.37.785"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1063\/1.464304"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c00769","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c00769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T08:50:11Z","timestamp":1718268611000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.4c00769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,13]]}},"alternative-id":["10.1021\/acs.jmedchem.4c00769"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00769","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00769.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00769.s002","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}